Search the Newsreel

Griffon Corp (GFF) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Griffon Corp (GFF), highlighting its strong earnings forecast score of 9.14 within the Homebuilding & Construction Supplies industry. Analysts have set an average price target of $100.00, with a "Strong Buy" rating from 7 analysts. The report …

Corsair Capital Management L.P. Makes New Investment in Ziff Davis, Inc. $ZD

Corsair Capital Management L.P. has established a new position in Ziff Davis, Inc. (NASDAQ:ZD) by purchasing 45,000 shares valued at approximately $1.9 million. This investment represents 0.12% of Ziff Davis and 0.3% of Corsair’s portfolio. Despite mixed analyst ratings and recent insider selling, institutional …

Cleveland-Cliffs Revenue Up on Continued Steel Demand

Cleveland-Cliffs reported a rise in first-quarter revenue, reaching $5.23 billion, driven by continued strong steel demand. The company also announced the appointment of its CFO, Celso Goncalves, to the additional role of president and a seat on the board of directors.

Ziff Davis Inc (ZD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Ziff Davis Inc (ZD), listing its major institutional holders and their respective proportions. It also categorizes shareholders by type and provides a quarterly breakdown of institutional shareholdings and recent activity of key investors. The report includes Ziff …

MONIMUS CAPITAL MANAGEMENT, LP's Ziff Davis Inc(ZD) Holding History

This article details MONIMUS CAPITAL MANAGEMENT, LP's historical holding in Ziff Davis Inc (ZD). As of March 31, 2026, the firm held 241,918 shares valued at $10.15 million, representing 2.81% of its portfolio. MONIMUS CAPITAL MANAGEMENT, LP initiated its position in Q1 2026, purchasing …

Griffon Corp (GFF) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Griffon Corp (GFF), listing its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding over time, and recent shareholder activity with changes in holdings. Additionally, it lists ETFs with holdings in Griffon …

Griffon Corp (GFF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Griffon Corp (GFF), detailing its regional revenue contributions. As of the last update, the company has not disclosed relevant data for business segments or profit contributions. The regional data shows the United States as the largest contributor, …

Intl Flavors & Fragrances Market Sentiment

This article provides an overview of market sentiment for International Flavors & Fragrances (IFF), detailing analyst consensus, short interest, options flow, and recent analyst actions. It highlights a "Buy" consensus from 19 analysts, decreasing short interest, and a bullish put/call ratio, alongside recent analyst …

CRDF|Cardiff Oncology Inc|Price:0.827|Chg%:-0.011

This article provides a detailed financial overview of Cardiff Oncology Inc. (CRDF), including its stock performance, key financial indicators, and historical data from income statements, balance sheets, and cash flow statements. It highlights the company's latest earnings report and future forecasts, offering investors comprehensive …

TradingKey

This article provides a detailed cash flow statement for International Flavors & Fragrances Inc (IFF), including operating, investing, and financing cash flows, spanning from FY2012Q1 to FY2026Q1. It highlights key financial figures such as operating cash flow of $850 million in FY2025 and capital …

Rice Hall James & Associates LLC Has $33.56 Million Position in Ziff Davis, Inc. $ZD

Rice Hall James & Associates LLC significantly increased its stake in Ziff Davis (NASDAQ:ZD) by 7.5% in the first quarter, now holding 799,818 shares valued at approximately $33.56 million. Ziff Davis currently holds a consensus "Hold" rating from analysts with an average target price …

Lombard Odier Asset Management USA Corp Sells 11,336 Shares of Griffon Corporation $GFF

Lombard Odier Asset Management USA Corp significantly reduced its stake in Griffon Corporation (NYSE:GFF) by 61.9% in the first quarter, selling 11,336 shares and retaining 6,975 shares valued at $507,000. This comes amidst notable insider selling by CEO Ronald J. Kramer and COO Robert …

Ziff Davis Inc (ZD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Ziff Davis Inc (ZD) by business segment and geographical region, updated as of April 6. The company's main revenue streams are advertising/performance marketing and subscription/licensing, with the United States being its dominant market.

GFF|Griffon Corp|Price:90.620|Chg%:+1.810

Griffon Corp (GFF) experienced a 2.04% increase, closing at $90.620. Despite a weak stock market performance recently, the company maintains strong fundamentals and a "Strong Buy" analyst rating with a target price of $118.43. Its fundamentals are stable, growth potential is high, and its …

Cardiff Oncology, Inc. Revenue Breakdown – NASDAQ:CRDF

Cardiff Oncology, Inc. (NASDAQ: CRDF) generated $593,000 USD in revenue last year from its top-performing segment, Novel Therapies for Cancers, a decrease from $683,000 USD in the prior year. All of the company's revenue last year came from the United States.

Cleveland-Cliffs Inc. Revenue Breakdown – NYSE:CLF

This article provides a brief overview of Cleveland-Cliffs Inc.'s revenue breakdown. In the last fiscal year, the company generated $18.61 billion USD, with the Steelmaking segment contributing the vast majority at $18.06 billion USD. The United States was the primary geographic contributor, accounting for …

15,615 Shares in Griffon Corporation $GFF Purchased by Walleye Capital LLC

Walleye Capital LLC recently acquired 15,615 shares of Griffon Corporation (NYSE:GFF) for approximately $1.135 million, marking a new position for the firm. This purchase is part of a broader trend of institutional investors adjusting their stakes, with institutions now owning 73.22% of Griffon's stock. …

Pale Fire Capital SE Has $116.79 Million Position in Ziff Davis, Inc. $ZD

Pale Fire Capital SE significantly increased its stake in Ziff Davis, Inc., boosting its holdings by 130% to 2.78 million shares valued at $116.79 million, making it their fourth-largest position. Other institutional investors like First Trust Advisors LP and Goldman Sachs Group Inc. also …

Ziff Davis, Inc. $ZD Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. significantly increased its stake in Ziff Davis (NASDAQ:ZD) by 28.9% in the first quarter. This comes as institutional ownership now accounts for 99.76% of the stock, while company insiders have been selling shares. Ziff Davis delivered slightly better-than-expected earnings and …

CLF|Cleveland-Cliffs Inc|Price:11.960|Chg%:+0.030

This article provides a comprehensive stock analysis of Cleveland-Cliffs Inc (CLF) by TradingKey. It highlights the company's relatively weak fundamentals but good growth potential, fair valuation, and very high institutional ownership. Despite a recent strong stock market performance, the analysis suggests weak underlying fundamentals …

Cardiff Oncology Inc (CRDF) Valuation: PE, PB & Fair Value Analysis

Cardiff Oncology Inc (CRDF) currently holds a valuation score of 6.15, placing it 356th out of 386 in the Biotechnology & Medical Research industry. Its P/E ratio stands at -1.24, which is significantly lower than its recent high and higher than its recent low. …

Cardiff Oncology Inc (CRDF) Institutional Confidence

Cardiff Oncology Inc (CRDF) has an institutional shareholding score of 3.00, placing it 192nd in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 35.32%, a significant decrease of 33.21% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.15% of shares …

ZD|Ziff Davis Inc|Price:51.600|Chg%:-0.210

Ziff Davis Inc. (ZD) closed at $51.60, down 0.41%, with a market cap of $1.91 billion. Analysts have a "Buy" rating with a target price of $49.40, indicating a potential downside, despite the stock's strong year-to-date performance. The company's fundamentals are considered healthy, growth …

Cleveland-Cliffs (CLF) Stock Faces Ongoing Losses As Q2 EPS Miss Undercuts Recovery Narrative

Cardiff Oncology Inc (CRDF) Financial Health: Profitability & Balance Sheet Analysis

Cardiff Oncology Inc (CRDF) currently holds a financial score of 5.79, ranking 327 out of 386 in the Biotechnology & Medical Research industry, indicating stable financial health but low operating efficiency. The company's latest quarterly revenue was $41.00K, marking a 62.39% year-over-year decrease, while …

Cardiff Oncology Inc (CRDF) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cardiff Oncology Inc (CRDF), highlighting its current price momentum score of 5.65 and its trading range between support at 0.61 and resistance at 1.24. It details various technical indicators like MACD, RSI, and moving averages, which predominantly …

Griffon (GFF) Rises Higher Than Market: Key Facts

In the latest trading session, Griffon (GFF) closed at $90.62, marking a +1.92% move from the previous day. This move outpaced the S&P 500's daily gain of 0.05%. At the same time, the Dow added 0.46%, and the tech-heavy Nasdaq lost 0.64%. Prior to …

A2RR9Q Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the International Flavors & Fragrances Inc. bond, A2RR9Q. It highlights that the current coupon rate is 1.80%, with the next interest payment scheduled for September 25, 2026. The piece encourages users to access more detailed coupon data …

CRDF|Cardiff Oncology Inc|Price:0.845|

Cardiff Oncology Inc. is a clinical-stage biotechnology company focused on developing novel therapies for various cancers using PLK1 inhibition. Their lead drug candidate, Onvansertib, is in clinical trials for indications like RAS-mutated metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, and …

Cleveland-Cliffs Inc (CLF) Stock Up 16.0% and Still Undervalued -- GF Score: 74/100

Cleveland-Cliffs Inc (CLF) shares recently rose 16.0% to $10.96, yet GuruFocus assesses the stock as "Fairly Valued" and potentially undervalued by 7.7% compared to its GF Value™ of $11.88. Despite a strong Valuation score of 8/10 and an Above Average GF Score™ of 74/100 …

Cleveland Cliffs (CLF) Promotes Celso Goncalves After Strong Q2 And Upbeat Outlook

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Cleveland-Cliffs (NYSE:CLF) reported strong Q2 results, with higher adjusted EBITDA, a smaller net loss, …

International Flavors & Fragrances Drops 5.3% in Broad Selloff

International Flavors & Fragrances Inc. (IFF) plunged 5.3% to $73.12, experiencing an outsized drop compared to its specialty chemicals peers amidst a broad sector selloff. The decline, which saw other companies like SHW, PPG, and RPM also fall, suggests investors are rotating out of …

Cleveland-Cliffs offers ‘bright’ Q3 outlook despite maintenance outages

Cleveland-Cliffs expects its adjusted EBITDA to more than double in Q3, forecasting $575 million, driven by rising steel prices, Section 232 tariffs, and strong automotive demand. The steel producer reported $286 million in adjusted EBITDA for Q2, its best quarter in two years, despite …

CLF Q2 Earnings and Sales Beat Estimates on Higher Steel Pricing

Cleveland-Cliffs Inc. CLF reported second-quarter 2026 adjusted loss of 20 cents per share, narrower than the Zacks Consensus Estimate of a loss of 21 cents and the year-ago loss of 51 cents. Revenues rose 5.9% year over year to $5.2 billion and surpassed the …

IFF|International Flavors & Fragrances Inc|Price:74.878|Chg%:+1.108

This article provides an overview of International Flavors & Fragrances Inc. (IFF), detailing its business segments, company information, and executive team. It highlights IFF as a creator and manufacturer of food, beverage, health and biosciences, and scent products. The article also includes details on …

Cleveland-Cliffs Stock Surges As Earnings Guidance Ignites Bulls

Cleveland-Cliffs Inc. (CLF) stock surged by over 9% and peaked at nearly 19% intraday after its Q2 earnings beat expectations. The company provided strong Q3 adjusted EBITDA guidance of $575 million, doubling Q2's $286 million, and expects Q3-Q4 EBITDA to more than double Q2 …